Genmab A/S (GMAB)
34.36
+1.34
(+4.06%)
USD |
NASDAQ |
Aug 25, 16:00
34.35
-0.01
(-0.03%)
After-Hours: 19:59
Genmab EPS Diluted (Quarterly) : 0.4903 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4903 |
| March 31, 2026 | 0.0833 |
| December 31, 2025 | 0.0461 |
| September 30, 2025 | 0.6431 |
| June 30, 2025 | 0.5537 |
| March 31, 2025 | 0.3052 |
| December 31, 2024 | 0.8529 |
| September 30, 2024 | 0.2917 |
| June 30, 2024 | 0.3132 |
| March 31, 2024 | 0.2938 |
| December 31, 2023 | 0.1395 |
| September 30, 2023 | 0.4662 |
| June 30, 2023 | 0.2963 |
| March 31, 2023 | 0.046 |
| December 31, 2022 | 0.1209 |
| September 30, 2022 | 0.5301 |
| June 30, 2022 | 0.41 |
| March 31, 2022 | 0.1063 |
| December 31, 2021 | 0.1663 |
| September 30, 2021 | 0.2135 |
| June 30, 2021 | 0.0752 |
| March 31, 2021 | 0.269 |
| December 31, 2020 | 0.1402 |
| September 30, 2020 | 0.1262 |
| June 30, 2020 | 0.7582 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0603 |
| December 31, 2019 | 0.336 |
| September 30, 2019 | 0.1234 |
| June 30, 2019 | 0.0203 |
| March 31, 2019 | 0.0178 |
| December 31, 2018 | 0.2055 |
| September 30, 2018 | 0.0451 |
| June 30, 2018 | 0.0673 |
| March 31, 2018 | 0.0528 |
| December 31, 2017 | 0.2001 |
| September 30, 2017 | -0.0014 |
| June 30, 2017 | 0.0733 |
| March 31, 2017 | 0.0037 |
| December 31, 2016 | 0.1973 |
| September 30, 2016 | 0.0459 |
| June 30, 2016 | 0.0413 |
| March 31, 2016 | -0.0028 |
| December 31, 2015 | 0.0946 |
| September 30, 2015 | 0.0343 |
| June 30, 2015 | 0.004 |
| March 31, 2015 | 0.0549 |
| December 31, 2014 | 0.02 |
| September 30, 2014 | 0.0494 |
| June 30, 2014 | -0.0085 |
| March 31, 2014 | 0.0323 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 2.033 |
| Ascendis Pharma A/S | 3.522 |
| Zealand Pharma A/S | 8.610 |
| Bavarian Nordic A/S | 0.4995 |
| Evaxion AS | -0.4464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 302.57M |
| Revenue (Quarterly) | 1.153B |
| Total Expenses (Quarterly) | 850.79M |
| Enterprise Value | 24.28B |
| Gross Profit Margin (Quarterly) | 92.73% |
| Profit Margin (Quarterly) | 26.23% |
| Earnings Yield | 3.68% |
| Operating Earnings Yield | 6.08% |
| Normalized Earnings Yield | 4.485 |